Showing results (1-10 of 86) with videos related to
Sort By:
Pageof 9
Molecular Cancer Therapeutics|February 20, 2015
PD-L1 Expression as a Predictive Biomarker in Cancer ImmunotherapySandip Pravin Patel, Razelle KurzrockCancer Metastasis Reviews|November 23, 2016
Next generation predictive biomarkers for immune checkpoint inhibitionYulian Khagi, Razelle Kurzrock, Sandip Pravin PatelFrontiers in Oncology|December 20, 2024
Clinical perspectives on the value of testing for <i>STK11</i> and <i>KEAP1</i> mutations in advanced NSCLCMichelle Shiller, Melissa Johnson, Robert Auber, et al.Journal of General Internal Medicine|May 8, 2019
GABA<sub>B</sub>R-Mediated Paraneoplastic Limbic Encephalitis Due To Thymic Small Cell CarcinomaTalya Bordin-Wosk, Sandip Pravin Patel, Sarah F HormanThe Oncologist|July 11, 2022
Patient Blood Type Is Associated With Response to Immune Checkpoint Blockade in Metastatic CancerRuifeng Chen, Kasim Hakimi, Xinlian Zhang, et al.Oncotarget|August 1, 2020
Rapid onset type 1 diabetes with anti-PD-1 directed therapyKaren Yun, Gregory Daniels, Kathryn Gold, et al.Surgical Oncology Clinics of North America|February 24, 2024
Immuno-Oncology: New Insights into Targets and TherapiesShiruyeh Schokrpur, Michael G White, Christina L Roland, et al.Journal of Thoracic Disease|May 31, 2014
Minimally invasive and robotic Ivor Lewis esophagectomyLingling Huang, Mark OnaitisCancer Treatment Reviews|January 9, 2026
Clinical overview of trophoblast surface antigen 2 antibody-drug conjugates in non-small cell lung cancerSandip Pravin Patel, Shirish Gadgeel, Mari Mino-Kenudson, et al.Mayo Clinic Proceedings. Innovations, Quality & Outcomes|June 14, 2019
Rebound Vertebral Fractures in a Patient With Lung Cancer After Oncology-Dose Denosumab Discontinuation: A Cautionary TaleAlexander Tyan, Sandip Pravin Patel, Shanna Block, et al.Pageof 9